BlackRock Investment Management, LLC - ISIS PHARMACEUTICALS INC ownership

ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109. A total of 294 filers reported holding ISIS PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 1.39 and the average weighting 0.3%.

Quarter-by-quarter ownership
BlackRock Investment Management, LLC ownership history of ISIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2015$4,704,000
-30.2%
116,376
-0.6%
0.01%
-25.0%
Q2 2015$6,741,000
-73.8%
117,136
-71.1%
0.01%
-76.5%
Q1 2015$25,762,000
+13.3%
404,622
+9.9%
0.03%
+13.3%
Q4 2014$22,733,000
+73.7%
368,206
+9.2%
0.03%
+66.7%
Q3 2014$13,090,000
+13.3%
337,105
+0.5%
0.02%
+12.5%
Q2 2014$11,556,000
-13.8%
335,453
+8.1%
0.02%
-15.8%
Q1 2014$13,408,000
+9.0%
310,292
+0.5%
0.02%
+5.6%
Q4 2013$12,305,000
+3.7%
308,852
-2.3%
0.02%
-10.0%
Q3 2013$11,866,000
+48.5%
316,098
+6.3%
0.02%
+42.9%
Q2 2013$7,990,000297,3760.01%
Other shareholders
ISIS PHARMACEUTICALS INC shareholders Q4 2014
NameSharesValueWeighting ↓
Crosspoint Capital Strategies, LLC 600$37,0000.01%
PRENTISS SMITH & CO INC 200$12,0000.01%
MARSHALL & SULLIVAN INC /WA/ 100$4,0000.01%
MASSMUTUAL TRUST CO FSB/ADV 0$00.00%
View complete list of ISIS PHARMACEUTICALS INC shareholders